SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BMO Raises Eli Lilly Price Target to $1,650, Keeps Outperform Rating

BMO raised its price target on Eli Lilly to $1,650 from $1,400 and maintained its Outperform rating.

LLY

Related stories